USP25 stabilises GLI1 through K48‐linked deubiquitination within a reciprocal regulatory circuit in osteoarthritis models
- 1Department of Rehabilitation Medicine The Seventh Affiliated Hospital Sun Yat‐sen University Shenzhen China
- 2Department of Urology The Seventh Affiliated Hospital Sun Yat‐sen University Shenzhen China
Abstract
Background Osteoarthritis (OA) is characterised by progressive articular cartilage degeneration, yet effective disease‐modifying targets remain limited. The post‐translational mechanisms sustaining Hedgehog/GLI1 signalling during OA progression remain incompletely understood. Methods Bioinformatic analyses of GEO datasets were performed to evaluate GLI1 expression across OA‐related tissue compartments. Independent cartilage datasets, paired human cartilage specimens, and primary human chondrocytes exposed to graded IL‐1β stimulation provided tissue‐ and cell‐relevant evidence. An unbiased deubiquitinase library screen combined with GLI1‐responsive luciferase assays was used to identify GLI1‐regulating deubiquitinases. The molecular function of USP25, its reciprocal regulation with GLI1, and the preclinical chondroprotective activity and target dependence of AZ1 were investigated in vitro and in vivo. Results GLI1 dysregulation in OA cartilage and primary human chondrocytes supported subsequent screening, which prioritised USP25 for mechanistic study. In paired cartilage from 24 OA patients, USP25 protein abundance was higher in grossly degenerated than in relatively preserved regions and showed a modest positive correlation with GLI1. USP25 directly interacted with GLI1, removed K48‐linked polyubiquitin chains, and limited its proteasomal degradation. Reciprocal gain‐ and loss‐of‐function and rescue experiments indicated that GLI1 substantially, but not exclusively, mediated USP25‐associated inflammatory and cartilage‐catabolic phenotypes. GLI1, in turn, bound the USP25 promoter and enhanced USP25 transcription, establishing a reciprocal regulatory circuit. AZ1 showed preclinical chondroprotective activity in primary human chondrocytes and DMM mice. Residual AZ1 activity after USP25 silencing indicated partial USP25 dependence. Conclusions These findings define a GLI1‐centred mechanistic branch of USP25 biology in OA‐relevant models and provide tissue‐level support for coordinated USP25‐GLI1 expression in human OA cartilage. The reciprocal USP25‐GLI1 circuit contributes to cartilage‐catabolic phenotypes, while AZ1 provides preclinical proof‐of‐concept as a pharmacological probe. Further studies are warranted to define target selectivity, long‐term safety, and clinical relevance.
Related
- Comprehensive regulatory and developmental landscape of cell–scaffold combination therapies for osteoarthritis
- Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials
- Cannabinoid CB1 Receptor Regulates Spinal Dorsal Horn Synaptic Plasticity in a Mouse Model of Neuropathic Pain through the CB1R/SREBP1/NAMPT/SIRT1 Metabolic Regulatory Framework
- SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
- Nuclear Myosin VI stabilises Ku-associated DNA ends during non-homologous end joining
BibTeX
@article{zhang2026usp25,
title = {{USP25 stabilises GLI1 through K48‐linked deubiquitination within a reciprocal regulatory circuit in osteoarthritis models}},
author = {Qian Zhang and Yinyan Ye and Yijie Huang and Jun Li and Dongfeng Huang},
journal = {Clinical and Translational Medicine},
year = {2026},
month = oct,
doi = {10.1002/ctm2.70851},
url = {https://doi.org/10.1002/ctm2.70851},
note = {CC BY},
}
RIS
TY - JOUR
TI - USP25 stabilises GLI1 through K48‐linked deubiquitination within a reciprocal regulatory circuit in osteoarthritis models
AU - Qian Zhang
AU - Yinyan Ye
AU - Yijie Huang
AU - Jun Li
AU - Dongfeng Huang
PY - 2026
DA - 2026/10/26
JO - Clinical and Translational Medicine
DO - 10.1002/ctm2.70851
UR - https://doi.org/10.1002/ctm2.70851
AB - Background Osteoarthritis (OA) is characterised by progressive articular cartilage degeneration, yet effective disease‐modifying targets remain limited. The post‐translational mechanisms sustaining Hedgehog/GLI1 signalling during OA progression remain incompletely understood. Methods Bioinformatic analyses of GEO datasets were performed to evaluate GLI1 expression across OA‐related tissue compartments. Independent cartilage datasets, paired human cartilage specimens, and primary human chondrocytes exposed to graded IL‐1β stimulation provided tissue‐ and cell‐relevant evidence. An unbiased deubiquitinase library screen combined with GLI1‐responsive luciferase assays was used to identify GLI1‐regulating deubiquitinases. The molecular function of USP25, its reciprocal regulation with GLI1, and the preclinical chondroprotective activity and target dependence of AZ1 were investigated in vitro and in vivo. Results GLI1 dysregulation in OA cartilage and primary human chondrocytes supported subsequent screening, which prioritised USP25 for mechanistic study. In paired cartilage from 24 OA patients, USP25 protein abundance was higher in grossly degenerated than in relatively preserved regions and showed a modest positive correlation with GLI1. USP25 directly interacted with GLI1, removed K48‐linked polyubiquitin chains, and limited its proteasomal degradation. Reciprocal gain‐ and loss‐of‐function and rescue experiments indicated that GLI1 substantially, but not exclusively, mediated USP25‐associated inflammatory and cartilage‐catabolic phenotypes. GLI1, in turn, bound the USP25 promoter and enhanced USP25 transcription, establishing a reciprocal regulatory circuit. AZ1 showed preclinical chondroprotective activity in primary human chondrocytes and DMM mice. Residual AZ1 activity after USP25 silencing indicated partial USP25 dependence. Conclusions These findings define a GLI1‐centred mechanistic branch of USP25 biology in OA‐relevant models and provide tissue‐level support for coordinated USP25‐GLI1 expression in human OA cartilage. The reciprocal USP25‐GLI1 circuit contributes to cartilage‐catabolic phenotypes, while AZ1 provides preclinical proof‐of‐concept as a pharmacological probe. Further studies are warranted to define target selectivity, long‐term safety, and clinical relevance.
SN - 2001-1326
ER -